Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
naltrexone (revia) (1 trial)
Behavior, Addictive (Phase 3)
Opioid-Related Disorders (Phase 3)
Trials (1 total)
Trial APIs (1 total)